Oxamflatin is primarily used in research settings as a potent histone deacetylase (HDAC) inhibitor. It has shown significant potential in studying epigenetic regulation, particularly in understanding gene expression and chromatin remodeling. In cancer research, Oxamflatin is utilized to investigate its effects on tumor cell growth and apoptosis, as HDAC inhibition can lead to the reactivation of tumor suppressor genes. Additionally, it is employed in studies exploring its role in neurodegenerative diseases, where epigenetic modifications are thought to play a critical role. Its ability to modulate gene expression makes it a valuable tool in developmental biology and stem cell research as well.